EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study is intended to investigate the safety and efficacy of a novel formulation of
oxcarbazepine that is released more slowly than the current formulation. The study medication
will be used as a treatment against partial epilepsy.